EyeGene Inc. (KOSDAQ:185490)

EyeGene Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	50,032	69,196	91,605	108,036	408,921	148,527
Market Cap Growth	-39.21%	-24.46%	-15.21%	-73.58%	175.32%	11.93%
Enterprise Value	24,949	38,542	52,919	41,816	313,462	127,760
Last Close Price	1851.00	2271.28	3783.99	4462.72	16945.90	8578.12
PS Ratio	12.62	20.62	29.31	20.41	126.13	44.16
PB Ratio	1.06	1.32	1.40	1.57	4.60	11.51
P/TBV Ratio	1.22	1.50	1.47	1.64	4.64	11.97
EV/Sales Ratio	6.29	11.49	16.93	7.90	96.68	37.99
Debt / Equity Ratio	0.05	0.05	0.03	0.04	0.04	1.33
Asset Turnover	0.06	0.05	0.04	0.06	0.04	0.07
Inventory Turnover	4.22	6.90	4.56	4.10	2.40	3.59
Quick Ratio	3.20	3.64	6.81	13.79	8.99	3.92
Current Ratio	3.34	3.75	6.88	13.99	9.23	4.26
Return on Equity (ROE)	-22.60%	-21.89%	-33.39%	-33.55%	-67.87%	-93.10%
Return on Assets (ROA)	-10.49%	-11.55%	-21.36%	-16.24%	-29.28%	-18.63%
Return on Capital (ROIC)	-12.40%	-13.54%	-24.38%	-18.33%	-35.59%	-25.42%
Earnings Yield	-22.89%	-17.53%	-23.04%	-24.02%	-8.45%	-10.01%
FCF Yield	-13.11%	-19.78%	-23.48%	-17.90%	-7.92%	-7.94%
Buyback Yield / Dilution	-10.63%	-24.87%	-0.94%	-13.22%	-36.98%	-3.62%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.